Protein, leucine, and hypertrophy: the real thresholds
The per-meal leucine threshold for young adults is approximately 0.24 g/kg body weight (~20-25 g protein, ~2.5-3 g leucine); older adults need ~0.4 g/kg/m…

For research and educational purposes only. Not medical advice.
Category: Fitness. 5 min read. By pepSmart Editorial. . .
Key takeaways
- Per-meal leucine threshold (young adults): approximately 0.24 g/kg body weight (~20-25 g protein for a 90 kg adult, ~2.5-3 g leucine) .
- Anabolic resistance with age: older adults need approximately 0.4 g/kg per meal (~40 g protein, ~4 g leucine) to clear the muscle-protein-synthesis threshold (Moore 2015 reanalysis) .
- Total daily protein for hypertrophy in resistance-trained adults: 1.6 g/kg/day is the meta-analytic upper threshold (Morton 2018, 49 trials, 1,863 participants); 1.6-2.2 g/kg/day is the practical range .
- Distribution across 3-5 meals is modestly better than skewed distribution (Mamerow 2014); total intake matters more than distribution within a sensible range .
- During energy deficit, high-protein intake (2.4 g/kg/day in Longland 2016 trial) plus resistance training preserves lean mass and produces fat loss; this is the most consistently effective non-pharmacologic intervention for body recomposition .
The leucine threshold idea
Branched-chain amino acids, and leucine in particular, are signaling molecules for muscle-protein synthesis (MPS). The classic threshold studies in the 2000s and 2010s used stable-isotope tracer methods (L-[ring-13C6]-phenylalanine infusion with serial muscle biopsy) to measure how meal protein quantity translated into a synthesis pulse .
Moore and colleagues 2009 established that 20 grams of high-quality protein produced a near-maximal MPS response in recreationally active young men post-exercise; 40 grams produced no further gain in MPS but did increase amino acid oxidation . Witard and colleagues 2014 replicated and refined the dose-response in resistance-trained young men, confirming the ~20-25 g per meal saturation point .
Macnaughton and colleagues 2016 pushed the dose-response further by including whole-body resistance exercise (rather than single-limb leg-only protocols), demonstrating that 40 g of whey produced larger MPS response than 20 g when more total muscle mass had been recruited. The threshold scales with the amount of muscle stimulated .
Anabolic resistance with age
Older adults appear to have a higher MPS threshold than young adults. The same tracer designs find that older adults need a larger leucine load to drive an equivalent synthesis pulse. Moore and colleagues 2015 pooled the young-men and older-men dose-response data and reported that the per-meal protein dose to maximally stimulate MPS is approximately 0.4 g/kg body weight in older adults, compared to 0.24 g/kg in young adults .
- Young adult per-meal MPS-saturating dose: approximately 0.24 g/kg body weight (~20-25 g protein for a 90 kg adult).
- Older adult per-meal MPS-saturating dose: approximately 0.4 g/kg body weight (~35-40 g protein for a 90 kg adult).
- Per-meal absolute target for older adults: approximately 30-40 g protein per meal at 3-4 meals daily.
- Per-meal leucine target: approximately 2.5-3.0 g for young adults; approximately 4.0 g for older adults.
- Whey protein leucine content: approximately 10 percent (so 25 g whey ~ 2.5 g leucine, 40 g whey ~ 4 g leucine).
- Common older-adult intake gap: intake surveys repeatedly find many older adults eating well under the ~1.0 g/kg/day that would support MPS, often skewed toward the evening meal; both patterns disadvantage MPS.
This matters clinically for sarcopenia prevention and for preserving lean mass in weight-loss populations: an older adult targeting hypertrophy or lean-mass preservation needs more protein per meal than a young adult to reach the same synthesis response.
Bolus vs frequency: what randomized data say
If a single meal saturates the synthesis pulse, distribution across the day should matter. Several short-term randomized trials have compared even distribution (around 4 meals of 0.4 g/kg body weight) against skewed distribution (one large protein meal plus smaller ones). Mamerow and colleagues 2014 randomized adults to even versus skewed protein distribution and reported that integrated 24-hour MPS was 25 percent higher in the even-distribution arm .
- Total daily protein still matters most for hypertrophy outcomes in resistance-trained populations.
- The Morton 2018 systematic review and meta-analysis of 49 trials in 1,863 participants identified 1.6 g/kg/day as the upper threshold beyond which additional protein produced no further hypertrophy gains .
- Practical range across the meta-analytic and tracer literature: 1.6-2.2 g/kg/day for resistance-trained adults pursuing hypertrophy.
- Distribution effects (Mamerow 2014 style) are smaller than total-intake effects in head-to-head comparisons.
- Timing relative to a training session has a small independent effect; a meal within a few hours of training covers it, and the old 'anabolic window' idea implies a far tighter timing window than the data support.
- Schoenfeld, Aragon, and Krieger's 2013 meta-analysis of protein-timing trials found the apparent timing benefit disappeared once total daily protein intake was matched between groups .
Protein quality and source
Protein quality (digestibility-corrected amino acid score, DIAAS) varies across food sources. Whey, casein, eggs, and dairy score high on the digestibility-corrected scales (DIAAS at or above 1.0); soy is the strongest of the common plant options; most other plant proteins score lower. Leucine density tracks the same pattern: whey sits near 10 percent leucine by protein weight, most other animal and dairy proteins are close behind, and grain proteins run lower.
For mixed-diet adults eating sufficient total protein from a variety of sources, the source-specific MPS differences wash out. For adults at the lower end of the intake range (vegan, low-protein), source matters more because the per-meal leucine load may not clear the threshold without specific high-leucine choices or larger total servings.
What this changes in practice
For people in a calorie deficit (including users of GLP-1 therapies), holding protein intake at the upper end of the range while losing weight is a lever supported by multiple randomized trials in the weight-loss literature . Longland and colleagues 2016 demonstrated that high-protein (2.4 g/kg/day) hypocaloric diets plus resistance training preserved lean mass and produced fat loss versus low-protein controls in young men . For holding onto lean mass during a deficit this is the most consistently effective non-pharmacologic lever there is, and no peptide changes that.
The thresholds are real but softer than the round numbers suggest
The per-meal saturation numbers came from young men doing single-limb exercise, and the picture has moved since. Macnaughton showed the threshold climbs when you train more muscle at once , and Trommelen and colleagues 2023 fed 100 g of protein and measured a larger and longer synthesis response than 25 g, with no clear upper limit . So treat the per-meal figure as a minimum worth clearing; there is no good evidence that protein eaten above it is wasted for muscle. Total daily protein in the gram-per-kilo range above is the number that drives hypertrophy: hit that first, spread it across the day if it is convenient, and eat more per meal as you age.
For research and educational purposes only. Not medical advice.
pepSmart has not commissioned independent clinical review of this article.
More on how we write and source these pieces: Editorial process and contributor disclosure and Sourcing posture.
Spot an error? Email corrections via /about.
Sources: 11 entries, all primary canon (PubMed-indexed human tracer studies and randomized-trial meta-analyses), last reviewed 2026-07-08.
Related tools
- Tirzepatide dose calculator - Run tirzepatide-focused vial draw math.
- GLP-1 conversion calculator - Convert a GLP-1 mg dose to U-100 units and ml.
- GLP-1 ramp planner - Preview a linear educational dose-step table.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- PK simulator overview - Public overview of the Pro pharmacokinetic simulator.
- Plateau analyzer overview - Public overview of the Pro plateau-pattern analyzer.
References
- [1] Churchward-Venne et al. J Physiol 2012: supplementing a suboptimal protein dose with leucine or essential amino acids stimulates myofibrillar protein synthesis (PMID 22451437) (PubMed)
- [2] Moore et al. Am J Clin Nutr 2009: ingested protein dose response of muscle and albumin protein synthesis (PMID 19056590) (PubMed)
- [3] Witard et al. Am J Clin Nutr 2014: myofibrillar muscle protein synthesis rates after 0/10/20/40 g whey (PMID 24257722) (PubMed)
- [4] Macnaughton et al. Physiol Rep 2016: the muscle protein synthesis response following whole-body resistance exercise is greater after 40 g than 20 g of whey protein (PMID 27511985) (PubMed)
- [5] Moore et al. J Gerontol A Biol Sci Med Sci 2015: protein ingestion to stimulate myofibrillar protein synthesis requires greater relative intakes in older versus younger men (PMID 25056502) (PubMed)
- [6] Mamerow et al. J Nutr 2014: dietary protein distribution affects MPS in healthy adults (PMID 24477298) (PubMed)
- [7] Morton et al. Br J Sports Med 2018: protein intake meta-analysis for muscle hypertrophy (PMID 28698222) (PubMed)
- [8] Wycherley et al. Am J Clin Nutr 2012: meta-analysis of randomized controlled trials of energy-restricted high-protein versus standard-protein diets (PMID 23097268) (PubMed)
- [9] Longland et al. Am J Clin Nutr 2016: higher protein during energy deficit promotes lean mass and fat loss (PMID 26817506) (PubMed)
- [10] Schoenfeld, Aragon, Krieger. J Int Soc Sports Nutr 2013: meta-analysis finding total protein intake, not timing, is the strongest predictor of hypertrophy (PMID 24299050) (PubMed)
- [11] Trommelen et al. Cell Rep Med 2023: the anabolic response to protein ingestion has no upper limit; 100 g produced a greater and more prolonged response than 25 g (PMID 38118410) (PubMed)
For research and educational purposes only. Not medical advice.